• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Periprocedural Management of Antithrombotics — Do Not Hold if you Can!
The decision to hold or not to hold antithrombotic (AT) medications for an endoscopic procedure rests on the balance of the procedural bleeding risk and the patient ’s risk of suffering a thromboembolic event (TE), including stroke, pulmonary embolism, deep vein thrombosis, angina, or a myocardial infarction. Guidelines have categorized procedures into those with high and low bleeding risk. AT may be continued if the bleeding risk is low. If the bleeding risk is high, AT medications should be held or modified.
Source: Clinical Gastroenterology and Hepatology - January 28, 2023 Category: Gastroenterology Authors: Heiko Pohl Tags: Editorial Source Type: research

Risk of Gastrointestinal Bleeding in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants: a Systematic Review and Meta-analysis
Non-vitamin K antagonist oral anticoagulants (NOACs) are convenient and effective in prevention and treatment of venous thromboembolism and prevention of stroke in patients with atrial fibrillation. However, these drugs have been associated with increased risk of gastrointestinal (GI) bleeding. We conducted a systematic review and meta-analysis to determine the risk of GI bleeding in patients receiving these drugs.
Source: Clinical Gastroenterology and Hepatology - April 27, 2017 Category: Gastroenterology Authors: Corey S. Miller, Alastair Dorreen, Myriam Martel, Thao Huynh, Alan N. Barkun Source Type: research

Risk of Gastrointestinal Bleeding in Patients Taking Non –Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-Analysis
Non –vitamin K antagonist oral anticoagulants (novel oral anticoagulants [NOACs]) are convenient and effective in the prevention and treatment of venous thromboembolism and the prevention of stroke in patients with atrial fibrillation. However, these drugs have been associated with an increased risk o f gastrointestinal (GI) bleeding. We conducted a systematic review and meta-analysis to determine the risk of GI bleeding in patients receiving these drugs.
Source: Clinical Gastroenterology and Hepatology - April 27, 2017 Category: Gastroenterology Authors: Corey S. Miller, Alastair Dorreen, Myriam Martel, Thao Huynh, Alan N. Barkun Source Type: research